https://es.marketscreener.com/cotizacion/accion/THIRD-HARMONIC-BIO-INC-143774951/noticia/Third-Harmonic-Bio-anuncia-la-interrupci-n-del-estudio-de-fase-1B-del-Thb001-en-la-urticaria-cr-ni-42563037/?utm_source=telegram&utm_medium=social&utm_campaign=share